London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Everything on the Table
Main trial USA
CEO from USA
Inventor from USA
Eliot Forster took F-Star to USA
New investor fund USA rules
NASDAQ ? USA
New Board members USA ?
Partner or T/O USA firm ?
Something is brewing Comms have gone quiet again.
Yup…Nasdaq here we come..
CC knows the USA market and oncology circles so much more opportunity for Avacta to move out of this British cesspit called AIM.
No founder with links to Wetherby holding them back now.
Come on CC get us out of here and LTH’s their losses back.
Which one is she shaping the sell out to 🤔
“ Dr Coughlin trained as an oncologist and immunologist at the University of Pennsylvania and her career has included roles at major biopharmaceutical companies including Wyeth, Pfizer and Novartis.”
“ Novartis has made 37 acquisitions across sectors such as Biopharmaceuticals, Life Sciences - US, Life Sciences - Europe and others. The company has spent over $75.9B for acquisitions.”
First things first.
Cohort 1 signed off yet?
End of April.
The King is dead.... long live the Queen.
All major BP’s are based in USA
Dollar & FDA main reasons
Thorno. =🤡. Calm before the storm. Nasdaq here we come !
Cash buyout from Novartis works to as would be a logical fit
Everything on the table could also include:
- Sell off / spin off diagnostics
- Inter day RNS?
+?
Plus
- FDA fast track approval
Fudders have gone masters have loaded up - now sitting waiting to happen
And it definitely will
Calm before. The storm
Something always brewing when no news from avacta. MASSIVE no news period.
Personally I'd like to know how the two weekly dosing is going.
It will just take a RNS stating AVA6000 is progressing from successful phase 1 clinical trials into phase 2 and there will be no looking back at what a bargain you could have bagged
“Calm before. The storm”…..thought we’d just gone thro the Storm, now we’re becalmed !
Fully funded till late 2025. -Top global scientists - Plus mile stone payments along the way
Fingers in many pies
A massive rns. Will drop soon
What’s not to like here .
Patience!
Ps and Fudders have gone a!
I'm waiting for this...
*Additional pre|CISIONTM targeted cancer therapies are being developed in the pre-clinical pipeline and have not yet been publicly disclosed.
*There is also significant longer-term potential to combine Avacta’s two platforms to create next generation targeted ‘drug conjugate’ cancer treatments.
There seems to a be a somewhat naïve belief here on the part of certain posters of questionable intellect that if you say the same thing over and over it will thereby become incontrovertibly true. Sorry to be the bearer of bad tidings - but that simply is not so.
Unfortunately Largo, until I actually read a statement of something happening in fact, all this future stuff has historically never happened. I am tired of reading about potential this, new developments that, pipeline opportunities, etc etc
More pressingly, it's now mid May ,where is the end of April update?
That's the recurring drag of this company, never delivers on time, never surprises to the upside and all the time new therapies, vaccines etc are being developed and publicised.
I will be delighted if AVCT does actually go forward with a surprise turn of speed, but its always hints of things to come in the future that somehow never quite materialise.
Is that you included notrex?
Morning. Wynbore. Did you enjoy. Your day off ?
Ps nortext . History says it all loool
I see you realised it was you I was referring to Watching? I guess the term 'questionable intellect' was the clue eh? LoL
Dear me what a 🤡
“More pressingly, it's now mid May ,where is the end of April update?”
What update? this is fabricated FUD. Just because the SMDC were expected to review cohort 1 data end of April doesn’t mean they don’t have approval to dose folk in the UK (parallel) already as per the results RNS May 1st.
“Avacta receives approval to enrol patients in the UK in the ongoing two-weekly dose escalation study”
Cohort 1 was in USA they now they have received approval for UK. Chris said results will be announced H2 along with dose expansion. Do better next time buddy. 💯👍